NCPA represented at annual FDA listening session on compounding ncpa.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from ncpa.org Daily Mail and Mail on Sunday newspapers.
On Jun 15, NCPA staff Steve Postal and NCPA members Steve Hoffart and Cheri Garvin will participate in the FDA’s annual listening session by speaking about compounding. Hoffart and Garvin will each be giving 5-minute statements.
On June 15, NCPA will be represented at FDA’s annual listening session on compounding by NCPA staff Steve Postal and NCPA members and meeting presenters Steve Hoffart and Cheri Garvin. NCPA submitted its written statement for the record ahead of the listening session on compounding, covering concerns with GFI #256 (compounding animal drugs from bulk substances), patient access to compounded bioidentical hormone therapy, drug shortages, and adverse event reporting.
NCPA members Cheri Garvin and Steven Hoffart made statements at the FDA’s annual drug compounding listening session on June 17. This listening session was an opportunity for stakeholders to voice their views on compounding to the FDA.
Leesburg, Virginia, police are hoping to find out who smashed through the doors of two businesses over the weekend the latest of more than a dozen such.